JP2022509366A5 - - Google Patents

Info

Publication number
JP2022509366A5
JP2022509366A5 JP2021547662A JP2021547662A JP2022509366A5 JP 2022509366 A5 JP2022509366 A5 JP 2022509366A5 JP 2021547662 A JP2021547662 A JP 2021547662A JP 2021547662 A JP2021547662 A JP 2021547662A JP 2022509366 A5 JP2022509366 A5 JP 2022509366A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutically acceptable
acceptable salt
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021547662A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022509366A (ja
JP7503561B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/057985 external-priority patent/WO2020092139A1/en
Publication of JP2022509366A publication Critical patent/JP2022509366A/ja
Publication of JP2022509366A5 publication Critical patent/JP2022509366A5/ja
Application granted granted Critical
Publication of JP7503561B2 publication Critical patent/JP7503561B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021547662A 2018-10-29 2019-10-25 新規ジペプチド化合物及びその使用方法 Active JP7503561B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862751984P 2018-10-29 2018-10-29
US62/751,984 2018-10-29
PCT/US2019/057985 WO2020092139A1 (en) 2018-10-29 2019-10-25 Novel dipeptide compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2022509366A JP2022509366A (ja) 2022-01-20
JP2022509366A5 true JP2022509366A5 (https=) 2022-10-20
JP7503561B2 JP7503561B2 (ja) 2024-06-20

Family

ID=70464360

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021547662A Active JP7503561B2 (ja) 2018-10-29 2019-10-25 新規ジペプチド化合物及びその使用方法

Country Status (10)

Country Link
US (1) US12209141B2 (https=)
EP (1) EP3873916B8 (https=)
JP (1) JP7503561B2 (https=)
KR (1) KR102882178B1 (https=)
CN (2) CN116813691B (https=)
AU (1) AU2019371209B2 (https=)
CA (1) CA3117599A1 (https=)
IL (1) IL282676B1 (https=)
TW (1) TWI870362B (https=)
WO (1) WO2020092139A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3117599A1 (en) * 2018-10-29 2020-05-07 Huahai Us Inc. Novel dipeptide compounds and uses thereof
CN118496301A (zh) * 2023-02-16 2024-08-16 丽珠医药集团股份有限公司 一种二肽类化合物的盐、其制备方法和用途
WO2024169765A1 (zh) * 2023-02-16 2024-08-22 上海华汇拓医药科技有限公司 一种二肽类化合物的盐、其制备方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
MX9201416A (es) * 1991-03-28 1992-10-01 Rhone Poulenc Rorer Int Peptidos y pseudopeptidos antitromboticos.
JP4561696B2 (ja) * 1994-01-27 2010-10-13 三菱化学株式会社 プロリンアミド誘導体
FR2793248B1 (fr) * 1999-05-03 2001-06-29 Adir Nouveaux derives de 2,3-methano-aminoacides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6774110B2 (en) * 2001-03-19 2004-08-10 Lg Life Sciences Ltd. Orally available peptidic thrombin inhibitors
FR2836143B1 (fr) * 2002-02-21 2004-04-16 Servier Lab Nouveaux derives d'acides amines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
EP1778616A1 (en) * 2004-08-09 2007-05-02 Cancer Research Technology Limited Alpha-ketoglutarates and their use as therapeutic agents
DE102004062864A1 (de) 2004-12-21 2006-06-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Folienbehälter
CN100502914C (zh) * 2005-10-24 2009-06-24 丽珠医药集团股份有限公司 一种治疗脑中风的中药组合物及其制备方法
MX2008012574A (es) * 2006-03-29 2008-10-10 Schering Corp Derivados de himbacina monociclitos y biciclicos utiles como antagonistas del receptor de trombina.
CN101784516B (zh) * 2007-06-13 2014-07-02 百时美施贵宝公司 作为凝血因子抑制剂的二肽类似物
AR079944A1 (es) 2010-01-20 2012-02-29 Boehringer Ingelheim Int Anticuerpo neutralizante de la actividad de un anticoagulante
CN102464701B (zh) * 2010-11-08 2015-10-21 上海医药工业研究院 一类新型化合物、其制备方法及用途
CN102796168B (zh) * 2011-05-27 2014-02-26 首都医科大学 一种具有溶血栓活性的化合物,及其制备方法和应用
CN103833827B (zh) * 2012-11-27 2016-08-03 上海医药工业研究院 一种酰胺类化合物、其药物组合物、制备方法及应用
AU2014278172B2 (en) * 2013-06-12 2018-08-09 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
CN106316975A (zh) * 2015-06-15 2017-01-11 山东轩竹医药科技有限公司 酰胺类化合物及其作为tgr5激动剂的应用
CA3117599A1 (en) * 2018-10-29 2020-05-07 Huahai Us Inc. Novel dipeptide compounds and uses thereof

Similar Documents

Publication Publication Date Title
JP7221021B2 (ja) 毒性アルデヒド関連疾患および処置
JP2022509366A5 (https=)
AU2001280546B2 (en) Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
HUP0300544A2 (hu) Integrin expresszálás inhibitorokat tartalmazó gyógyszerkészítmények
JP2020517732A5 (https=)
JP2004509114A5 (https=)
JP2004509113A5 (https=)
KR940005566A (ko) 퀴놀린 화합물
CA2694270A1 (en) Substituted aryloxazoles and the use thereof
JP2004509117A5 (https=)
RU2001107897A (ru) Фармацевтическая композиция для лечения гепатита
JP2004532250A (ja) 線維性疾患又は他の適応症の治療方法
JP2018536641A5 (https=)
CA2412968A1 (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors
RU2005123394A (ru) Диаминовые производные
RU2013125480A (ru) Стимуляторы sgc
JP2013500314A5 (https=)
AU2001280546A1 (en) Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
JP2021523887A (ja) XIIa因子インヒビター
JP2004502756A5 (https=)
ME00685B (me) Preparati za tretiranje i prevenciju arterijske tromboze i korišćenje inhibitora faktora xa samog ili u kombinaciji sa plateletnim antiagregacionim agensom
JP2021522327A5 (https=)
WO2009087285A4 (fr) 5,6-diaryles pyridines substitues en position 2 et 3, leur preparation et leur application en therapeutique
JP2002179572A (ja) アレルギー性眼疾患治療剤
CA2523196A1 (en) Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals